A number of ADS Travel Grants will be awarded to junior investigators who have an abstract accepted for presentation at the ADS/ADEA Australasian Diabetes Congress in Sydney. The number and size of grants will be determined according to the number and suitability of applications and the funds available. Applications will be prioritised using abstract review scores. It is anticipated that the awards will represent a substantial contribution to the individual’s travel costs to the meeting.

Eligibility is as follows:

1. A financial member of the ADS for 12 months at the time of application (Member must have joined as an approved member of ADS from June 2018 and Paid subs for 2019)
2. In training for a higher degree eg. PhD, MD, fellowship or medical specialty
3. Supported by a statement from the candidate’s supervisor or department head indicating the nature of their present position and the availability of other sources of financial support for their travel to the Meeting
4. Travel Grants will be made directly to the member and not institution

Note: Applicants must not be in receipt of a travel grant from any other body to attend the ADS/ADEA Australasian Diabetes Congress or a meeting in association with the ADS/ADEA ADC.

Applications Closing Date: Monday 8 July 2019

To apply: Please click on ‘Apply for ADS Travel Grant’ below and complete the online application form and please ensure that you upload your supporting documentation. The successful applicants will be advised in writing one week prior to the meeting and travel grants will be paid following the ADC. Please contact Linda Valenzisi from the ADS Secretariat for any further information by email to linda@diabetessociety.com.au

Apply for ADS Travel Grant here

This Mid-Career Award supporting the career of a clinical diabetes researcher has been made possible by the generosity of Dr Ranji Wikramanayake, a long-standing member of the Australian Diabetes Society.

The Australian Diabetes Society invites applications for a Mid-Career Diabetes Research Award from endocrinology/diabetes clinicians who are members of the Australian Diabetes Society (ADS) and are between 6-15 years’ post-doctoral degree.  Applications can be nominated by financial members of the ADS or by self-nomination.

The award is to recognise significant contributions to diabetes research by a clinician and to support further advancement of those achievements.

The successful candidate will deliver the ADS Ranji and Amara Wikramanayake Clinical Diabetes Award Lecture at the 2019 ADS/ADEA Australasian Diabetes Congress to be held at the International Convention Centre from 21 to 23 August 2019. In addition, the awardee will be required to provide a written report on their further achievements (projects, presentations, publications, funding, community engagement) within 18 months of accepting the award.

The award is for A$40,000 and will be presented at the conclusion of the award lecture along with a commemorative plaque.

The selection criteria are:

• Is a clinician who has provided significant contributions to diabetes research
• Is a financial member of the ADS (Paid to 2019)
• Is between 6-15 years post-doctoral degree
• Is available to give the award lecture at the ADS/ADEA Australasian Diabetes Congress in 2019

Applications, accompanied by a full curriculum vitae, are now invited and should be in the form of a letter not exceeding 2 pages outlining the applicant’s suitability for the award.

Applications should be emailed to Dr Sof Andrikopoulos, ADS CEO at ceo@diabetessociety.com.au

Applications Closing Date: Monday 27 May 2019

Eligibility

The Lifetime Achievement Award recognises an individual who has:

1. An established history of distinguished service to education, clinical practice and/or research and training in diabetes
2. Made a lasting contribution to diabetes
3. Exhibited leadership and mentorship in diabetes research and/or clinical practice on a state, national and/or international level

Selection of the nominee is made on the basis of the candidate’s significant, fundamental contributions to diabetes (whether in research, clinical practice, leadership, mentorship or other); the lasting impact of these contributions to the sector; and the demonstration of a lifetime commitment to diabetes.

Nominees must have:

1. Made a positive impact to diabetes [at either state/territory or national level]
2. The respect of professional peers
3. General acknowledgement as having reached a pinnacle of their profession
4. Demonstrated, over an extended period of time, a contribution which has included either research and/or clinical practice, professional leadership and service to the diabetes community
5. Held positions of leadership
6. Personal integrity
7. On-going membership with the ADS

Nominees will be recognised and the winner of the award will be announced at the Annual General Meeting held at ADS/ADEA Australasian Diabetes Congress each year.

Nomination process

Please submit two letters of recommendation including a full curriculum vitae of the nominee to the ADS CEO, Dr Sof Andrikopoulos via email: ceo@diabetessociety.com.au One letter of recommendation must be by a financial member of the ADS.

Nominations Closing Date: Monday 1 July 2019

The Kellion Foundation and the Australian Diabetes Society invite applications for the Award for an Australian who has made an outstanding contribution in diabetes research, clinical or service areas in Australia.  This is an annual award that commenced in the year 2000 and is the premier award bestowed on an individual by the Australian Diabetes Society.

Nominations are now called for this Award which will be considered by a review committee consisting of the Australian Diabetes Society Council as well as prominent Australian diabetes experts and if appropriate international referees.  Nominations may be self-initiated, initiated by colleagues or by organisations.

The recipient of the Kellion Award must be a financial ADS member and will be required to deliver the ADS Kellion Plenary Lecture at the Australian Diabetes Society/Australian Diabetes Educators Association Australasian Diabetes Congress to be held at the International Convention Centre, Sydney, NSW from 21 – 23 August 2019.  The Award will include a return business class airfare to the meeting, accommodation for the duration of the meeting, registration, and a commemorative plaque.  There is also a A$10,000 honorarium.

Nominations should include a letter (not exceeding 2 pages) clearly stating the basis of the nomination and a full curriculum vitae of the nominee.  Nominations made in the previous years have been retained and will be considered also.

Nominations Closing Date: Monday 6 May 2019

Please forward nominations or for further enquiries to:
Dr Sof Andrikopoulos
Australian Diabetes Society
145 Macquarie St
SYDNEY NSW 2000
Ph: 02 9256 5462
Email: ceo@diabetessociety.com.au

Previous recipients of this prestigious award include:  Len Harrison (2000), Don Chisholm (2001), George Jerums (2002), Paul Zimmet (2003), Tim Welborn (2004), Mark Cooper (2005), David James (2006), Ted Kraegen (2007), Martin Silink (2008), Michael Horowitz (2009), Dennis Yue (2010), Frank Alford (2011), Joseph Proietto (2012), Peter Colman (2013), Timothy Davis (2014), Stephen Colagiuri (2015), Kerin O’Dea (2016), Mark Febbraio (2017), Jonathan Shaw (2018)

The Best ADS Clinical Presentation Award in memory of Dr Paul Lee is to the value of A$1,250. The finalists will be categorised into Clinical Research and the award will be given to the best oral presentation by an ADS member at the ADS/ADEA Australasian Diabetes Congress in Sydney as judged by peer review and a committee appointed by the ADS Council. 2019 is the inaugural year of this annual award.

Eligibility is as follows:

1. A financial member of the ADS for 12 months at the time of application (Member must have joined as an approved member of ADS from May 2018 and Paid subs for 2019)
2. Applicant must be a mid-career clinical researcher (4-10 years post-doctoral)
3. Each applicant must provide a supporting statement indicating that the work presented is substantially the candidate’s own work
4. 6-8 applicants will be selected from abstracts to present in the award session.

To submit your application form please click here.

To apply: Please click above and complete the online application form. Please ensure that you have uploaded your supporting documentation. You must tick the box during abstract submission. Please contact Linda Valenzisi from the ADS Secretariat for any further information by email to linda@diabetessociety.com.au

Applications Closing Date: Thursday 2 May 2019

ADS Poster Awards for both Basic Science and Clinical Research will be on offer during the ADS/ADEA Australasian Diabetes Congress in Sydney, NSW. ADS Poster Awards are to the value of A$500 each.

Eligibility is as follows:

1. A financial member of the ADS (Paid subs for 2019)
2. Applicant must be an early career researcher
3. You must be standing by your poster at the time of the poster session
4. Each applicant must provide a supporting statement including one signed by his/her supervisor or department head, indicating that the work presented is substantially the candidate’s own work

To apply: Please click on ‘ADS ADC Awards Application Form’ below and complete the online application form. Please ensure that you have uploaded your supporting documentation. You must tick the box during abstract submission. Please contact Linda Valenzisi from the ADS Secretariat for any further information by email to linda@diabetessociety.com.au.

Applications Closing Date: Thursday 2 May 2019

ADS ADC Awards Application Form

The ADS-Pincus Taft Young Investigator Award is to the value of A$2000. The finalists will be categorised into Basic Science and the award will be given to the best oral presentation by a junior ADS member at the ADS/ADEA Australasian Diabetes Congress in Sydney as judged by peer review and a committee appointed by the ADS Council.

Eligibility is as follows:

1. A financial member of the ADS for 12 months at the time of application (Member must have joined as an approved member of ADS from May 2018 and Paid subs for 2019)
2. Applicant must not be more than 2 years beyond the award of a doctoral degree (PhD, MD) or fellowship (FRACP)
3. Each applicant must provide a supporting statement including one signed by his/her supervisor or department head, indicating that the work presented is substantially the candidate’s own work
4. Previous winners of this award are in-eligible to apply
5. Finalist applicants must present work of abstract submitted for the conference; if not they will be in-eligible to receive the award

6-8 applicants will be selected from abstracts to present in the ADS-Pincus Taft Young Investigators Session.

To apply: Please click on ‘ADS ADC Awards Application Form’ below and complete the online application form. Please ensure that you have uploaded your supporting documentation. You must tick the box during abstract submission. Please contact Linda Valenzisi from the ADS Secretariat for any further information by email to linda@diabetessociety.com.au.

Applications Closing Date: Thursday 2 May 2019

ADS ADC Awards Application Form

The ADS President’s Young Investigator Award is to the value of A$2000. The finalists will be categorised into Clinical Research and the award will be given to the best oral presentation by a junior ADS member at the ADS/ADEA Australasian Diabetes Congress in Sydney as judged by peer review and a committee appointed by the ADS Council.

Eligibility is as follows:

1. A financial member of the ADS for 12 months at the time of application (Member must have joined as an approved member of ADS from May 2018 and Paid subs for 2019)
2. Applicant must not be more than 2 years beyond the award of a doctoral degree (PhD, MD) or fellowship (FRACP)
3. Each applicant must provide a supporting statement including one signed by his/her supervisor or department head, indicating that the work presented is substantially the candidate’s own work
4. Previous winners of this award are in-eligible to apply
5. Finalist applicants must present work of abstract submitted for the conference; if not they will be in-eligible to receive the award

6-8 applicants will be selected from abstracts to present in ADS Presidents Young Investigators Session.

To apply: Please click on ‘ADS ADC Awards Application Form’ below and complete the online application form. Please ensure that you have uploaded your supporting documentation. You must tick the box during abstract submission. Please contact Linda Valenzisi from the ADS Secretariat for any further information by email to linda@diabetessociety.com.au

Applications Closing Date: Thursday 2 May 2019

ADS ADC Awards Application Form

The Roche ADC-registration Assistance Grants provide eligible recipients with 50% of full registration to attend the Australasian Diabetes Congress (formerly ADS-ADEA Annual Scientific Meeting) in Sydney from 21 to 23 August 2019.

Applications close at 9am Tuesday 30 April 2019.

For more information and to submit your application, please click here.

This program is sponsored by Roche Diabetes Care.

The Roche Travel Grants provide five travel grants of $1,000 to five ADEA members are available to attend the Australasian Diabetes Congress (formerly ADS-ADEA Annual Scientific Meeting) in Sydney from 21 to 23 August 2019.

Applications close at 9am Wednesday 15 May 2019.

For more information and to submit your application, please visit click here.

This program is sponsored by Roche Diabetes Care.